{
    "medicine_id": "479429ba8388aca66d78b85a38d9cda639020425",
    "platform_id": "DB00844",
    "metadata": {
        "name": "Nalbuphine Hci 10 mg 1mL Injection solution",
        "composition": "10 mg 1mL Nalbuphine",
        "clinical_particulars": {
            "therapeutic_indications": "For the relief of moderate to severe pain",
            "contraindications": {
                "disease": "Oral acute LD50 is 1100 mg kg in dog Symptoms of overdose include primarily sleepiness and mild dysphoria",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Nalbuphine is a synthetic opioid agonist antagonist analgesic of the phenanthrene series Nalbuphine s analgesic potency is essentially equivalent to that of morphine on a milligram basis The opoioid antagonist activity of nalbuphine is about one fourth to that of nalorphine and 10 times to that of pentazocine Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose When administered following or concurrent with mu agonist opioid analgesics e g morphine oxymorphone fentanyl nalbuphine may partially reverse or block opioid induced respiratory depression from the mu agonist analgesic Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00921",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Nalbuphine can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Nalbuphine may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Nalbuphine may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Nalbuphine may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Nalbuphine may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB06274",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alvimopan"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hyponatremia can be increased when Nalbuphine is combined with Desmopressin"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of bradycardia can be increased when Succinylcholine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Nalbuphine may increase the opioid antagonism activities of Methylnaltrexone"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "Nalbuphine may increase the opioid antagonism activities of Naloxegol"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Nalbuphine may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Nalbuphine may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Pseudoephedrine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may increase the analgesic activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "The risk or severity of adverse effects can be increased when Mecamylamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Pentolinium is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Trimethaphan is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Fenoterol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01496",
                        "description": "The risk or severity of adverse effects can be increased when Dihydro 2 thioxo 5 5 2 trifluoromethyl phenyl 2 furanyl methyl 4 6 1H 5H pyrimidinedione is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of adverse effects can be increased when Agmatine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Promethazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Metixene"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Profenamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Timepidium"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when Clozapine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of adverse effects can be increased when Imipramine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of adverse effects can be increased when Nortriptyline is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when Amoxapine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Fluphenazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thioridazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Moricizine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Trifluoperazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Perphenazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Periciazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Acepromazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Aceprometazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when BL 1020 is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Propiopromazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Perazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Chlorproethazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Thiazinam is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Perphenazine enanthate is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Nalbuphine may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Morphine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Codeine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Meperidine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The therapeutic efficacy of Levorphanol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The therapeutic efficacy of Remifentanil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The therapeutic efficacy of Diphenoxylate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The therapeutic efficacy of Dezocine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The therapeutic efficacy of Dihydroetorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The therapeutic efficacy of Diamorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The therapeutic efficacy of Bezitramide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The therapeutic efficacy of Etorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The therapeutic efficacy of Dextromoramide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The therapeutic efficacy of Desomorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The therapeutic efficacy of Carfentanil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The therapeutic efficacy of Dihydrocodeine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The therapeutic efficacy of Dihydromorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The therapeutic efficacy of Ketobemidone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The therapeutic efficacy of DPDPE can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The therapeutic efficacy of Lofentanil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The therapeutic efficacy of Opium can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The therapeutic efficacy of Normethadone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The therapeutic efficacy of Piritramide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The therapeutic efficacy of Alphaprodine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The therapeutic efficacy of Nicomorphine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The therapeutic efficacy of Meptazinol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The therapeutic efficacy of Phenoperidine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The therapeutic efficacy of Phenazocine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The therapeutic efficacy of Tilidine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The therapeutic efficacy of Carfentanil C 11 can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The therapeutic efficacy of Benzhydrocodone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when Phenytoin is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Valproic acid is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Sulpiride is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of adverse effects can be increased when Quinine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of adverse effects can be increased when Cisapride is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Trimipramine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Furazolidone"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Procaine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Nalbuphine can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Nalbuphine can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The therapeutic efficacy of Zinc can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The therapeutic efficacy of Dantron can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The therapeutic efficacy of Emodin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The therapeutic efficacy of Linaclotide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The therapeutic efficacy of Magnesium trisilicate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The therapeutic efficacy of Magnesium acetate tetrahydrate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09483",
                        "description": "The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The therapeutic efficacy of Mineral oil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The therapeutic efficacy of Docusate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The therapeutic efficacy of Plantago seed can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The therapeutic efficacy of Castor oil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The therapeutic efficacy of Sennosides can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The therapeutic efficacy of Plecanatide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13180",
                        "description": "The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The therapeutic efficacy of Magnesium acetate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The therapeutic efficacy of Magnesium can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The therapeutic efficacy of Prucalopride can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The therapeutic efficacy of Alloin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00504",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Levallorphan"
                    },
                    {
                        "drugbank-id": "DB01548",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Diprenorphine"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Nalmefene"
                    },
                    {
                        "drugbank-id": "DB11490",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Nalorphine"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naldemedine"
                    },
                    {
                        "drugbank-id": "DB12013",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Axelopran"
                    },
                    {
                        "drugbank-id": "DB12341",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with LY 2456302"
                    },
                    {
                        "drugbank-id": "DB12543",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Samidorphan"
                    },
                    {
                        "drugbank-id": "DB12585",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Ondelopran"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Naloxone"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Temazepam"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Alprazolam"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Chlordiazepoxide"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Adinazolam"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clorazepic acid"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flurazepam"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Halazepam"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxazepam"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of constipation can be increased when Nalbuphine is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of respiratory depression can be increased when Nalbuphine is combined with Metaxalone"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The therapeutic efficacy of Torasemide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "The therapeutic efficacy of Ethoxzolamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The therapeutic efficacy of Triamterene can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The therapeutic efficacy of Metolazone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The therapeutic efficacy of Amiloride can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The therapeutic efficacy of Furosemide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The therapeutic efficacy of Eplerenone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The therapeutic efficacy of Methazolamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The therapeutic efficacy of Mannitol can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The therapeutic efficacy of Indapamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The therapeutic efficacy of Conivaptan can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The therapeutic efficacy of Diazoxide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The therapeutic efficacy of Diclofenamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Polythiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The therapeutic efficacy of Quinethazone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Drospirenone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The therapeutic efficacy of Theobromine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The therapeutic efficacy of Piretanide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "The therapeutic efficacy of Ularitide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The therapeutic efficacy of Indisulam can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The therapeutic efficacy of Azosemide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The therapeutic efficacy of Efonidipine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "The therapeutic efficacy of Mersalyl can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Isosorbide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "The therapeutic efficacy of Canrenone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "The therapeutic efficacy of Rolofylline can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "The therapeutic efficacy of Spiradoline can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The therapeutic efficacy of Cicletanine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "The therapeutic efficacy of Meticrane can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "The therapeutic efficacy of Mefruside can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Mebutizide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "The therapeutic efficacy of Clorexolone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "The therapeutic efficacy of Clofenamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "The therapeutic efficacy of Fenquizone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "The therapeutic efficacy of Clopamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "The therapeutic efficacy of Muzolimine can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "The therapeutic efficacy of Xipamide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The therapeutic efficacy of Epitizide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "The therapeutic efficacy of Potassium can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "The therapeutic efficacy of Potassium cation can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "Naphazoline may increase the central nervous system depressant CNS depressant activities of Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Nalbuphine is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "Nalbuphine can cause a decrease in the absorption of Clopidogrel resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Nalbuphine is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ziprasidone is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Haloperidol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "Nalbuphine can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Nalbuphine is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Nalbuphine is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}